CORRECTION FROM SOURCE: Wellgistics Health Secures $50M ELOC Facility for XRP Treasury Reserve and Real-Time Payments Infrastructure and Other General Ops
CEO Brian Norton emphasizes that this move positions Wellgistics at the intersection of healthcare and fintech, focusing on building efficient infrastructure rather than traditional healthcare assets.
Il CEO Brian Norton sottolinea che questa mossa posiziona Wellgistics all'incrocio tra sanità e fintech, concentrandosi sulla costruzione di infrastrutture efficienti piuttosto che su asset tradizionali nel settore sanitario.
El CEO Brian Norton enfatiza que este movimiento posiciona a Wellgistics en la intersección entre salud y fintech, enfocándose en construir infraestructuras eficientes en lugar de activos tradicionales en salud.
CEO 브라이언 노튼은 이 조치가 전통적 의료 자산 대신 효율적인 인프라 구축에 집중하며 Wellgistics를 의료와 핀테크의 교차점에 위치시킨다고 강조했습니다.
Le PDG Brian Norton souligne que cette démarche positionne Wellgistics à l'intersection de la santé et de la fintech, en se concentrant sur la construction d'infrastructures efficaces plutôt que sur des actifs traditionnels de santé.
CEO Brian Norton betont, dass dieser Schritt Wellgistics an die Schnittstelle von Gesundheitswesen und Fintech positioniert und den Fokus auf den Aufbau effizienter Infrastruktur statt traditioneller Gesundheitsvermögenswerte legt.
- Implementation of XRP enables ultra-fast 3-5 second transaction settlements vs. traditional 1-3 day transfers
- Significant cost reduction in transfers ($0.0002 vs. $10-$30 for bank wires)
- Secured $50M ELOC facility to support the initiative
- Strategic positioning ahead of competitors in healthcare-fintech integration
- Multiple revenue opportunities through XRP-backed credit lines and smart rebates
- Early adoption of cryptocurrency in healthcare sector carries implementation risks
- Regulatory uncertainty surrounding cryptocurrency use in healthcare payments
- Potential volatility in XRP value could affect treasury reserves
Insights
Wellgistics adopts XRP for treasury and payments with $50M ELOC; offers potential benefits despite implementation uncertainties.
Wellgistics Health's initiative to incorporate XRP into its operations represents a significant strategic pivot that merges healthcare infrastructure with blockchain technology. The $50 million Equity Line of Credit facility isn't merely capital raising—it's the foundation for what appears to be a comprehensive infrastructure overhaul intended to address fundamental inefficiencies in healthcare payments.
The company's rationale for XRP adoption centers on compelling technical advantages: settlement in 3-5 seconds versus days for traditional banking, transaction costs of
However, this announcement reveals more about intention than implementation. While the company presents a detailed vision, the press release uses future-oriented language ("upon successful commercialization") indicating this remains largely conceptual. The
The market context section tellingly lists upcoming developments rather than established precedents (CME futures launch, Mastercard's identification of XRP as a bridge currency), highlighting both the innovative nature of this approach and its speculative elements. Wellgistics is positioning itself at the intersection of two high-growth sectors—healthcare infrastructure and blockchain-based financial systems—but the execution timeline and regulatory considerations remain undefined.
For a pharmaceutical distribution company to adopt cryptocurrency for treasury reserves represents a significant departure from industry norms. While the efficiency benefits are compelling, the company will need to navigate regulatory complexity in both healthcare and cryptocurrency domains. The initiative shows ambition but requires careful execution to deliver on its promised transformation of healthcare payments infrastructure.
The correction is to the headline only
TAMPA, FL / ACCESS Newswire / May 8, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner.
This XRP payment initiative is supported by Wellgistics Health's
"At Wellgistics Health, we challenge the idea that healthcare has to be tethered to legacy systems, bloated intermediaries, and slow-moving money," said Brian Norton, CEO of Wellgistics Health. "We are developing a platform that connects manufacturers directly to pharmacies and patients-bypassing the red tape and placing control back in the hands of those who deliver care. Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that's long been starved of all three. I believe that the future winners in healthcare won't be the companies with the biggest buildings…they'll be those with the fastest rails, cleanest data, and most efficient platforms. We're betting on infrastructure…not inertia."
Why XRP? Why Now?
We believe that there are certain advantages to integrating XRP and its related infrastructure into its healthcare ecosystem. These include, among others:
Speed: XRP settles transactions in 3-5 seconds vs. 1-3 days for ACH or wire transfers, allowing for near real-time settlement among pharmacies, suppliers, and manufacturers.
Cost: Less than
$0.00 02 per transfer vs.$10 -$30 for standard bank wires.Transparency: All transactions are logged on the XRP Ledger for real-time compliance, rebate tracking, and auditability.
Scope: Supports global vendor payouts with significantly low foreign exchange and wire transfer fees.
Flexibility: Allows for XRP-backed lines of credit to support independent pharmacy liquidity.
These benefits will support faster vendor payments, performance-based rebates, and embedded liquidity tools for pharmacies and manufacturers in the Wellgistics ecosystem.
Use Cases Across the Ecosystem
Real-time settlement between pharmacies, suppliers, and manufacturers
Smart rebates calculated automatically based on real-world data
XRP-backed credit lines to enhance liquidity for independent pharmacies
Global vendor payouts with near-zero foreign transaction and wire costs
Immutable compliance layer supporting DSCSA reporting and pricing validation
"We're working to unlock capital velocity with surgical precision," said Mark DiSiena, CFO of Wellgistics Health. "We believe that our XRP-powered infrastructure will allow us to run leaner, faster, and with more control than any of our peers in pharma infrastructure."
The Market Is Moving-And Wellgistics Intends to Lead
XRP is gaining momentum across global institutions, as demonstrated by the following:
CME Group to launch XRP futures for institutional access
→ CME will launch cash-settled XRP futures contracts in May 2025 to meet rising institutional demand.¹Mastercard identifies XRP as a bridge currency for cross-border payments
→ Mastercard's 2025 report highlights XRP as a top solution for global remittances and cost efficiency.²Ripple acquires prime brokerage firm Hidden Road for
$1.25B
→ This landmark acquisition expands XRP's footprint in institutional liquidity and asset servicing.³Ripple receives regulatory licensing in Dubai
→ Ripple became the first blockchain payment provider licensed by the DFSA to operate crypto-based financial services in the UAE.⁴Ripple expands real-world cross-border payment corridors in Brazil and Portugal
→ Ripple now enables live XRP-powered remittances between LATAM and Europe through its partnership with Unicâmbio.⁵
"Others are waiting for change. We're building it," Norton added. "I strongly believe that our XRP initiative positions Wellgistics Health years ahead of the curve-and squarely at the center of where healthcare and fintech converge."
About Wellgistics Health
Wellgistics Health, Inc. (NASDAQ:WGRX) is a publicly traded healthcare infrastructure company transforming how medications move, get priced, and reach patients. The company operates across pharmaceutical distribution, prescription technology, and clinical fulfillment-connecting over 150 direct manufacturer contracts to a growing network of more than 6,000 independent pharmacies nationwide.
Wellgistics Health delivers real-time prescription hub services, compliance-driven logistics, and patient-first fulfillment models, while equipping pharmacies with embedded financial, clinical, and digital tools. Its integrated platform supports a wide range of therapeutic categories-from specialty-lite to maintenance meds-by eliminating friction, accelerating reimbursements, and creating direct, transparent pathways between manufacturers, providers, pharmacies, and patients.
For more information, visit: www.wellgisticshealth.com.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.
Media Contact: media@wellgisticshealth.com
Investor Relations: investors@wellgisticshealth.com
References
CME Group Press Release: CME to Launch XRP Futures
AInvest: Mastercard Identifies XRP as Bridge Currency
Reuters: Ripple Acquires Hidden Road for
$1.25B BusinessWire: Ripple Licensed by DFSA in Dubai
PYMNTS: Ripple Launches Portugal-Brazil Corridor
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire